tirzepatide trial New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Weight-loss drug tirzepatide may lower
Pay in 4 interest-free payments of $7.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7















:max_bytes(150000):strip_icc():focal(999x0:1001x2)/south-park-end-of-obesity-051524-1-d9e409b714e94c7bb21ba322782e838e.jpg)









